News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
EU Extends Review Of Planned Sanofi-Aventis (France) / Zentiva Deal
January 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, Jan 16 (Reuters) - The European Commission on Friday extended the deadline for its review of plans by French pharmaceuticals producer Sanofi-Aventis (SASY.PA) to buy Czech generic drugmaker Zentiva (ZNTVsp.PR).
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
Sanofi (France)
MORE ON THIS TOPIC
Layoff Tracker
BMS Hits New Jersey With Even More Layoffs; 110 Affected
November 17, 2025
·
85 min read
·
BioSpace Editorial Staff
Layoffs
Bayer Layoffs Continued in Q3 but CEO Says Cuts Should Be ‘Incremental’ Moving Forward
November 14, 2025
·
1 min read
·
Angela Gabriel
C-suite
UPDATE: Novo Foundation Completes Board Takeover After Shareholder Pushback
November 14, 2025
·
5 min read
·
Annalee Armstrong
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
·
1 min read
·
Annalee Armstrong
